90 results
Page 4 of 5
8-K
EX-99.1
pt8 6wp9t
23 Sep 19
Regulation FD Disclosure
8:00am
8-K
EX-3.1
m867l iv88
18 Sep 19
Unregistered Sales of Equity Securities
9:40pm
8-K
EX-99.1
69r8 riep22wlnfh
9 Sep 19
Other Events
12:00am
8-K
5t02tw
27 Jun 19
Regulation FD Disclosure
12:04pm
8-K
EX-99.1
gjounnip0bgysxvj
27 Jun 19
Regulation FD Disclosure
12:04pm
8-K
EX-99.1
e1qlwfq2nn1ta5e
11 Mar 19
Regulation FD Disclosure
2:51pm
8-K
bowxmia36 7hi2vd
11 Mar 19
Regulation FD Disclosure
2:51pm
8-K
EX-3.1
o3iv9jm6j 3b
21 Feb 19
Ovid Therapeutics Announces Pricing of $30 Million of Securities in Concurrent Public Offerings of Common and Preferred Stock
4:53pm
8-K
EX-99.1
nvvg b88jw649bu3wq0a
19 Feb 19
Results of Operations and Financial Condition
4:01pm
8-K
dubt7rb
19 Feb 19
Results of Operations and Financial Condition
4:01pm
8-K
h3j8qx
7 Jan 19
Regulation FD Disclosure
6:31am
8-K
EX-99.1
6w9zuhjb
7 Jan 19
Regulation FD Disclosure
6:31am
8-K
EX-99.2
k1yinbfila7zq11p
17 Dec 18
Ovid Therapeutics Announces Phase 1b/2a Results of OV935/TAK-935 in Adults with Rare Epilepsies
8:05am
8-K
bjy9g mjckdab
17 Dec 18
Ovid Therapeutics Announces Phase 1b/2a Results of OV935/TAK-935 in Adults with Rare Epilepsies
8:05am
8-K
EX-99.2
23m9jj4cypu
25 Oct 18
Regulation FD Disclosure
10:25am
8-K
EX-99.1
xb5qm8a6d nl6
1 Oct 18
Regulation FD Disclosure
12:00am